Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Regulated and prolonged expression of mIFNα in immunocompetent mice mediated by a helper-dependent adenovirus vector

Abstract

A major goal in gene therapy is to develop efficient gene transfer protocols that allow tissue-specific, long-term and tightly regulated expression of the desired transgene. This objective is becoming more attainable through the co-evolution of gene transfer vectors and regulation systems. The ideal vector should efficiently transduce non-dividing cells with minimal toxicity, thus endowing the system with persistent transgene expression. The helper-dependent adenovirus vectors meet these requirements, as demonstrated in various studies in the literature. The most promising regulation system is the tet-on system, which has low basal transcriptional activity and high inducibility. To explore the regulated transgene expression in the context of a helper-dependent vector, we constructed the HD-TET-IFN vector, containing the mIFNα gene under the control of the tetracycline inducible transactivator rtTA2s-S2. Mice injected with HD-TET-IFN showed high levels of serum mIFNα only upon transcriptional activation. The transgene expression was reinducible to the same high level up to 3 months p.i., and the amount of expressed cytokine could be regulated by dosing doxycycline. Transcriptional activation of mIFNα induced by doxycycline resulted in prolonged survival and reduced liver damage in HD-TET-IFN-injected mice challenged with a lethal dose of coronavirus. Activation of antiviral genes mediated by doxycycline-dependent mIFNα expression was also observed at low HD-TET-IFN doses. The possibility of controlling gene expression by the combination of HD vectors and the latest tet-on transactivator also holds promise for studying gene function in other animal models.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Russell WC . Update on adenovirus and its vectors J Gen Virol 2000 81: 2573–2604

    Article  CAS  PubMed  Google Scholar 

  2. Lusky M et al. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted J Virol 1998 72: 2022–2032

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Schiedner G et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity (published erratum appears in Nat Genet 1998; 18: 298) Nat Genet 1998 18: 180–183

    Article  CAS  PubMed  Google Scholar 

  4. Thomas CE et al. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases Proc Natl Acad Sci USA 2000 97: 7482–7487

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Maione D et al. Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector Hum Gene Ther 2000 11: 859–868

    Article  CAS  PubMed  Google Scholar 

  6. Parks RJ et al. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal Proc Natl Acad Sci USA 1996 93: 13565–13570

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kochanek S et al. High-capacity adenoviral vectors for gene transfer and somatic gene therapy Hum Gene Ther 1999 10: 2451–2459

    Article  CAS  PubMed  Google Scholar 

  8. Corti O et al. Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease Proc Natl Acad Sci USA 1999 96: 12120–12125

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Burcin MM et al. Adenovirus-mediated regulable target gene expression in vivo Proc Natl Acad Sci USA 1999 96: 355–360

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Baron U, Bujard H . Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances Meth Enzymol 2000 327: 401–421

    Article  CAS  Google Scholar 

  11. Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters Proc Natl Acad Sci USA 1992 89: 5547–5551

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Gossen M et al. Transcriptional activation by tetracyclines in mammalian cells Science 1995 268: 1766–1769

    Article  CAS  PubMed  Google Scholar 

  13. Kafri T, van Praag H, Gage FH, Verma IM . Lentiviral vectors: regulated gene expression Mol Ther 2000 1: 516–521

    Article  CAS  PubMed  Google Scholar 

  14. Pitzer C et al. In vivo manipulation of interleukin-2 expression by a retroviral tetracycline (tet)-regulated system Cancer Gene Ther 1999 6: 139–146

    Article  CAS  PubMed  Google Scholar 

  15. Rizzuto G et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation Proc Natl Acad Sci USA 1999 96: 6417–6422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Urlinger S et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity Proc Natl Acad Sci USA 2000 97: 7963–7968

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Eto T, Takahashi H . Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon Nat Med 1999 5: 577–581

    Article  CAS  PubMed  Google Scholar 

  18. Aurisicchio L et al. Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis J Virol 2000 74: 4816–4823

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Protzer U et al. Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection Proc Natl Acad Sci USA 1999 96: 10818–10823

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Carlow DA, Teh SJ, Teh HS . Specific antiviral activity demonstrated by TGTP, a member of a new family of interferon-induced GTPases J Immunol 1998 161: 2348–2355

    CAS  PubMed  Google Scholar 

  21. Sandig V et al. Optimization of the helper-dependent adenovirus system for production and potency in vivo Proc Natl Acad Sci USA 2000 97: 1002–1007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Kistner A et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice Proc Natl Acad Sci USA 1996 93: 10933–10938

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Kato Y et al. Effect of exogenous mouse interferon on murine fulminant hepatitis induced by mouse hepatitis virus type 2 Dig Dis Sci 1986 31: 177–180

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Minagawa H, Takenaka A, Mohri S, Mori R . Protective effect of recombinant murine interferon beta against mouse hepatitis virus infection Antiviral Res 1987 8: 85–95

    Article  CAS  PubMed  Google Scholar 

  25. Schowalter DB et al. Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice J Virol 1999 73: 4755–4766

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Hitt MM, Addison CL, Grahm FL . Human adenovirus vectors for gene transfer into mammalian cells Adv Pharmacol 1997 40: 137–206

    Article  CAS  PubMed  Google Scholar 

  27. Rivera VM et al. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer Proc Natl Acad Sci USA 1999 96: 8657–8662

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Rivera VM et al. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer

  29. Pastore L et al. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors Hum Gene Ther 1999 10: 1773–1781

    Article  CAS  PubMed  Google Scholar 

  30. Morral N et al. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons Proc Natl Acad Sci USA 1999 96: 12816–12821

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank S Germoni and M Aquilina for animal care, C Toniatti for critically reading of the manuscript and Domenico Lazzaro for the immunohistochemistry. We also thank J Clench for editorial assistance and G Bifolchetti for graphics.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aurisicchio, L., Bujard, H., Hillen, W. et al. Regulated and prolonged expression of mIFNα in immunocompetent mice mediated by a helper-dependent adenovirus vector. Gene Ther 8, 1817–1825 (2001). https://doi.org/10.1038/sj.gt.3301596

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.gt.3301596

Keywords

This article is cited by

Search

Quick links